Literature DB >> 8976852

Screening for sexually transmitted diseases in an HIV testing clinic; uptake and prevalence.

S Madge1, J Elford, M C Lipman, J Mintz, M A Johnson.   

Abstract

OBJECTIVE: To estimate the prevalence of sexually transmitted diseases (STDs) and the acceptability of STD screening among people seeking an HIV antibody test in an established free standing HIV testing clinic.
DESIGN: A 9 month period prevalence study conducted between August 1993 and April 1994.
SETTING: The Same Day Testing Clinic (SDTC) for HIV antibodies at the Royal Free Hampstead NHS Trust Hospital, London.
SUBJECTS: 242 males and 160 females attending the Same Day Testing Clinic. OUTCOME MEASURES: The prevalence of STDs including gonorrhoea, chlamydia, syphilis and hepatitis B and the percentage of clinic attenders accepting an STD screen.
RESULTS: Of those invited to take part in the study 69% of the males (242/350) and 59% (160/269) of the females agreed to be screened although for a variety of reasons not everyone agreed to a full screen. Two cases of untreated syphilis, no cases of gonorrhoea and six cases of chlamydia were detected. Four people had active, previously undiagnosed herpes while three had genital warts. Evidence of previously unknown hepatitis B infection was found in 26 people. Despite a high level of previous contact with genitourinary medicine services, uptake of hepatitis B vaccination among those homosexual men eligible for immunisation was low (28%; 23/83). Nine (4%) of the males, but none of the females screened for STD were found to be HIV antibody positive.
CONCLUSION: Among people seeking an HIV antibody test in an established free standing HIV testing clinic, the prevalence of acute STDs was low. However, evidence of previously undiagnosed hepatitis B infection was found in a number of subjects and uptake of vaccination among those most at risk had been low. While opportunistic screening for STD was acceptable to almost two thirds of HIV testing clinic attenders, a substantial minority nonetheless declined this offer. Selective STD screening could be offered to those people seeking an HIV test who report never having been screened before, as both cases of positive syphilis serology and all those of chlamydia were in people who had not previously been screened. All those at risk for hepatitis B infection should be encouraged to establish their infection status and be immunised where appropriate.

Entities:  

Mesh:

Year:  1996        PMID: 8976852      PMCID: PMC1195703          DOI: 10.1136/sti.72.5.347

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  16 in total

1.  Sexual lifestyles and HIV risk.

Authors:  A M Johnson; J Wadsworth; K Wellings; S Bradshaw; J Field
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

2.  Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics.

Authors:  H H Handsfield; L L Jasman; P L Roberts; V W Hanson; R L Kothenbeutel; W E Stamm
Journal:  JAMA       Date:  1986-04-04       Impact factor: 56.272

3.  Detection, treatment, and follow up of women with Chlamydia trachomatis infection seeking abortion in inner city general practices.

Authors:  L Southgate; J Treharne; R Williams
Journal:  BMJ       Date:  1989-11-04

4.  A simple method for the detection of Chlamydia trachomatis infections in general practice.

Authors:  H J Longhurst; N Flower; B J Thomas; P E Munday; A Elder; M Constantinidou; J Wilton; D Taylor-Robinson
Journal:  J R Coll Gen Pract       Date:  1987-06

5.  Universal named testing of pregnant women for HIV.

Authors:  D J Goldberg; F D Johnstone
Journal:  BMJ       Date:  1993-05-01

6.  Screening for cervical Chlamydia trachomatis infections in two Dutch populations.

Authors:  E A Thewessen; W I van der Meijden; H J Doppenberg; P G Mulder; J H Wagenvoort; E Stolz; M F Michel
Journal:  Genitourin Med       Date:  1990-10

7.  Effect of volume and rate of contrast medium injection on intravenous digital subtraction angiographic contrast medium curves.

Authors:  F H Burbank; W R Brody; B R Bradley
Journal:  J Am Coll Cardiol       Date:  1984-08       Impact factor: 24.094

Review 8.  General practice update: chlamydia infection in women.

Authors:  P Oakeshott; P Hay
Journal:  Br J Gen Pract       Date:  1995-11       Impact factor: 5.386

9.  The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies.

Authors:  M J Alter; S C Hadler; H S Margolis; W J Alexander; P Y Hu; F N Judson; A Mares; J K Miller; L A Moyer
Journal:  JAMA       Date:  1990-03-02       Impact factor: 56.272

10.  A cost-based decision analysis for Chlamydia screening in California family planning clinics.

Authors:  A I Trachtenberg; A E Washington; S Halldorson
Journal:  Obstet Gynecol       Date:  1988-01       Impact factor: 7.661

View more
  4 in total

1.  Screening for sexually transmitted diseases in an HIV testing clinic: uptake and prevalence.

Authors:  N A Smith; E M Carlin; F C Boag
Journal:  Genitourin Med       Date:  1997-06

Review 2.  Sexual transmission and prevention of the hepatitis viruses A-E and G.

Authors:  M G Brook
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

3.  The prevalence of sexually transmitted pathogens in patients presenting to a Casablanca STD clinic.

Authors:  J Heikel; S Sekkat; F Bouqdir; H Rich; B Takourt; F Radouani; N Hda; S Ibrahimy; A Benslimane
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

Review 4.  Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies.

Authors:  E J Adams; A Charlett; W J Edmunds; G Hughes
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.